Wanbury Limited reports 11.6% growth in revenue for Q2 FY25, EBITDA surges 19.6%
Wanbury Limited, a leading pharmaceutical company with a global footprint in active pharmaceutical ingredients (APIs) and domestic branded formulations, has announced a stellar financial performance ... Read More
Alembic Pharmaceuticals secures final approval from FDA for hypertension drug
Alembic Pharmaceuticals Limited has successfully secured final approval from the US Food and Drug Administration (USFDA) for its Diltiazem Hydrochloride Extended-Release Capsules USP, in strengths ... Read More
Zydus Lifesciences bags FDA approval for Fludrocortisone Acetate Tablets, boosting U.S. market presence
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to produce Fludrocortisone Acetate Tablets USP, 0.1 mg, according ... Read More
Indoco Remedies secures final USFDA approval for generic Cetirizine Hydrochloride tablets
Indoco Remedies Limited has secured a significant regulatory win by receiving final approval from the United States Food and Drug Administration (USFDA) for its generic ... Read More
Alembic Pharmaceuticals wins big with FDA approval for new allergy eye drops
In a major development that could impact the over-the-counter pharmaceutical market, Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration ... Read More
Zydus Lifesciences bags FDA tentative approval for Enzalutamide Tablets for prostate cancer treatment
Zydus Lifesciences Limited has secured tentative approval from the United States Food and Drug Administration (USFDA) for its Enzalutamide Tablets, available in 40 mg and ... Read More
Dr. Reddy’s joins forces with Gilead Sciences to launch HIV drug Lenacapavir in India and 120 countries
In a historic development for HIV treatment worldwide, Dr. Reddy's Laboratories has announced a new partnership with Gilead Sciences to manufacture and commercialize a revolutionary ... Read More
Biocon faces regulatory heat as USFDA flags critical issues at its Bengaluru facility
In a significant development that has sent shockwaves through the biotechnology industry, Biocon Ltd. has come under fire from the U.S. Food and Drug Administration ... Read More
Zydus Lifesciences launches fight against prostate cancer with new FDA-approved drug enzalutamide
Zydus Lifesciences Limited has achieved a significant milestone in the pharmaceutical industry. The company recently received final approval from the United States Food and Drug ... Read More
Alembic Pharmaceuticals secures USFDA approval for new Paliperidone extended-release tablets
Alembic Pharmaceuticals Limited has achieved a major milestone in the pharmaceutical industry. On September 27, 2024, the company proudly announced that it received final approval ... Read More